Trial
NCT00780000
Clinical Trial of Intravenous Alvespimycin in Patients With Her2 Positive Breast Cancer
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Bristol-Myers Squibb
Collaborators
—
Condition
Breast Cancer
Intervention
Alvespimycin
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-11-04